AKASTOR ASA (AKAST.OL) Fundamental Analysis & Valuation

OSL:AKAST • NO0010215684

Current stock price

14.98 NOK
+0.2 (+1.35%)
Last:

This AKAST.OL fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

1

1. AKAST.OL Profitability Analysis

1.1 Basic Checks

  • In the past year AKAST has reported negative net income.
  • AKAST had a positive operating cash flow in the past year.
  • In multiple years AKAST reported negative net income over the last 5 years.
  • The reported operating cash flow has been mixed in the past 5 years: AKAST reported negative operating cash flow in multiple years.
AKAST.OL Yearly Net Income VS EBIT VS OCF VS FCFAKAST.OL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 1B -1B

1.2 Ratios

  • With a Return On Assets value of -2.46%, AKAST is not doing good in the industry: 80.56% of the companies in the same industry are doing better.
  • AKAST has a worse Return On Equity (-2.77%) than 80.56% of its industry peers.
Industry RankSector Rank
ROA -2.46%
ROE -2.77%
ROIC N/A
ROA(3y)5.94%
ROA(5y)5.3%
ROE(3y)6.26%
ROE(5y)6.89%
ROIC(3y)N/A
ROIC(5y)N/A
AKAST.OL Yearly ROA, ROE, ROICAKAST.OL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 -10 20 -20

1.3 Margins

  • With a decent Gross Margin value of 31.46%, AKAST is doing good in the industry, outperforming 63.89% of the companies in the same industry.
  • In the last couple of years the Gross Margin of AKAST has declined.
  • AKAST does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 31.46%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-28.67%
GM growth 5Y-7.02%
AKAST.OL Yearly Profit, Operating, Gross MarginsAKAST.OL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200 400

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. AKAST.OL Health Analysis

2.1 Basic Checks

  • AKAST does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • AKAST has about the same amout of shares outstanding than it did 1 year ago.
  • AKAST has more shares outstanding than it did 5 years ago.
  • AKAST has a better debt/assets ratio than last year.
AKAST.OL Yearly Shares OutstandingAKAST.OL Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M 250M
AKAST.OL Yearly Total Debt VS Total AssetsAKAST.OL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B 10B

2.2 Solvency

  • The Debt to FCF ratio of AKAST is 8.35, which is on the high side as it means it would take AKAST, 8.35 years of fcf income to pay off all of its debts.
  • The Debt to FCF ratio of AKAST (8.35) is worse than 63.89% of its industry peers.
  • AKAST has a Debt/Equity ratio of 0.04. This is a healthy value indicating a solid balance between debt and equity.
  • AKAST has a better Debt to Equity ratio (0.04) than 80.56% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.04
Debt/FCF 8.35
Altman-Z N/A
ROIC/WACCN/A
WACC10.46%
AKAST.OL Yearly LT Debt VS Equity VS FCFAKAST.OL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 2B 4B

2.3 Liquidity

  • A Current Ratio of 2.28 indicates that AKAST has no problem at all paying its short term obligations.
  • Looking at the Current ratio, with a value of 2.28, AKAST is in the better half of the industry, outperforming 75.00% of the companies in the same industry.
  • AKAST has a Quick Ratio of 2.25. This indicates that AKAST is financially healthy and has no problem in meeting its short term obligations.
  • AKAST has a better Quick ratio (2.25) than 75.00% of its industry peers.
Industry RankSector Rank
Current Ratio 2.28
Quick Ratio 2.25
AKAST.OL Yearly Current Assets VS Current LiabilitesAKAST.OL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B 4B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

1

3. AKAST.OL Growth Analysis

3.1 Past

  • The earnings per share for AKAST have decreased strongly by -129.91% in the last year.
  • Looking at the last year, AKAST shows a very negative growth in Revenue. The Revenue has decreased by -57.59% in the last year.
  • AKAST shows a very negative growth in Revenue. Measured over the last years, the Revenue has been decreasing by -40.53% yearly.
EPS 1Y (TTM)-129.91%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-87.5%
Revenue 1Y (TTM)-57.59%
Revenue growth 3Y-63.2%
Revenue growth 5Y-40.53%
Sales Q2Q%17.78%

3.2 Future

  • Based on estimates for the next years, AKAST will show a quite strong growth in Earnings Per Share. The EPS will grow by 15.22% on average per year.
  • The Revenue is expected to decrease by -18.49% on average over the next years. This is quite bad
EPS Next Y56.83%
EPS Next 2Y103.3%
EPS Next 3Y18.52%
EPS Next 5Y15.22%
Revenue Next Year-76.76%
Revenue Next 2Y-6.52%
Revenue Next 3Y-27.51%
Revenue Next 5Y-18.49%

3.3 Evolution

  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
AKAST.OL Yearly Revenue VS EstimatesAKAST.OL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 5B 10B 15B
AKAST.OL Yearly EPS VS EstimatesAKAST.OL Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 2 -2 -4

More info and screens

Find the best growth stocksShow best growing peers

4

4. AKAST.OL Valuation Analysis

4.1 Price/Earnings Ratio

  • AKAST reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • A Price/Forward Earnings ratio of 6.93 indicates a rather cheap valuation of AKAST.
  • Based on the Price/Forward Earnings ratio, AKAST is valued cheaper than 88.89% of the companies in the same industry.
  • AKAST's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 37.39.
Industry RankSector Rank
PE N/A
Fwd PE 6.93
AKAST.OL Price Earnings VS Forward Price EarningsAKAST.OL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20 30

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of AKAST indicates a slightly more expensive valuation: AKAST is more expensive than 75.00% of the companies listed in the same industry.
  • 72.22% of the companies in the same industry are cheaper than AKAST, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 120.72
EV/EBITDA 91.19
AKAST.OL Per share dataAKAST.OL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15

4.3 Compensation for Growth

  • AKAST's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • AKAST's earnings are expected to grow with 18.52% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y103.3%
EPS Next 3Y18.52%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. AKAST.OL Dividend Analysis

5.1 Amount

  • AKAST does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

AKAST.OL Fundamentals: All Metrics, Ratios and Statistics

AKASTOR ASA

OSL:AKAST (4/13/2026, 3:31:03 PM)

14.98

+0.2 (+1.35%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryEnergy Equipment & Services
Earnings (Last)02-12
Earnings (Next)04-29
Inst Owners2.71%
Inst Owner ChangeN/A
Ins Owners2.52%
Ins Owner ChangeN/A
Market Cap4.10B
Revenue(TTM)391.00M
Net Income(TTM)-148.00M
Analysts85.45
Price Target19.89 (32.78%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly Dividend0.75
Dividend Growth(5Y)N/A
DP-137.84%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)16.9%
Min Revenue beat(2)-6.44%
Max Revenue beat(2)40.24%
Revenue beat(4)1
Avg Revenue beat(4)3.64%
Min Revenue beat(4)-13.82%
Max Revenue beat(4)40.24%
Revenue beat(8)4
Avg Revenue beat(8)0.56%
Revenue beat(12)5
Avg Revenue beat(12)-6.66%
Revenue beat(16)8
Avg Revenue beat(16)-7.85%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)25.93%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)77.25%
Revenue NY rev (3m)63.47%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 6.93
P/S 10.5
P/FCF 120.72
P/OCF 95.45
P/B 0.77
P/tB 0.77
EV/EBITDA 91.19
EPS(TTM)-1.01
EYN/A
EPS(NY)2.16
Fwd EY14.44%
FCF(TTM)0.12
FCFY0.83%
OCF(TTM)0.16
OCFY1.05%
SpS1.43
BVpS19.47
TBVpS19.47
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -2.46%
ROE -2.77%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 31.46%
FCFM 8.7%
ROA(3y)5.94%
ROA(5y)5.3%
ROE(3y)6.26%
ROE(5y)6.89%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-28.67%
GM growth 5Y-7.02%
F-Score4
Asset Turnover0.06
Health
Industry RankSector Rank
Debt/Equity 0.04
Debt/FCF 8.35
Debt/EBITDA 5.29
Cap/Depr 15.79%
Cap/Sales 2.3%
Interest Coverage N/A
Cash Conversion 104.88%
Profit Quality N/A
Current Ratio 2.28
Quick Ratio 2.25
Altman-Z N/A
F-Score4
WACC10.46%
ROIC/WACCN/A
Cap/Depr(3y)202.35%
Cap/Depr(5y)135.2%
Cap/Sales(3y)19.4%
Cap/Sales(5y)15.44%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-129.91%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-87.5%
EPS Next Y56.83%
EPS Next 2Y103.3%
EPS Next 3Y18.52%
EPS Next 5Y15.22%
Revenue 1Y (TTM)-57.59%
Revenue growth 3Y-63.2%
Revenue growth 5Y-40.53%
Sales Q2Q%17.78%
Revenue Next Year-76.76%
Revenue Next 2Y-6.52%
Revenue Next 3Y-27.51%
Revenue Next 5Y-18.49%
EBIT growth 1Y-102.58%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year311.77%
EBIT Next 3Y47.9%
EBIT Next 5YN/A
FCF growth 1Y-97.91%
FCF growth 3YN/A
FCF growth 5Y-25.08%
OCF growth 1Y-97.58%
OCF growth 3YN/A
OCF growth 5Y-27.25%

AKASTOR ASA / AKAST.OL Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for AKASTOR ASA?

ChartMill assigns a fundamental rating of 3 / 10 to AKAST.OL.


What is the valuation status of AKASTOR ASA (AKAST.OL) stock?

ChartMill assigns a valuation rating of 4 / 10 to AKASTOR ASA (AKAST.OL). This can be considered as Fairly Valued.


How profitable is AKASTOR ASA (AKAST.OL) stock?

AKASTOR ASA (AKAST.OL) has a profitability rating of 1 / 10.


Can you provide the financial health for AKAST stock?

The financial health rating of AKASTOR ASA (AKAST.OL) is 5 / 10.


What is the expected EPS growth for AKASTOR ASA (AKAST.OL) stock?

The Earnings per Share (EPS) of AKASTOR ASA (AKAST.OL) is expected to grow by 56.83% in the next year.